2025-06-01 2026-05-31 false No description of principal activity Capium Accounts Production 1.1 15743429 2025-06-01 2026-05-31 15743429 bus:AbridgedAccounts 2025-06-01 2026-05-31 15743429 bus:Micro-entities 2025-06-01 2026-05-31 15743429 bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 15743429 bus:SmallCompaniesRegimeForAccounts 2025-06-01 2026-05-31 15743429 bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 15743429 2025-06-01 2026-05-31 15743429 2026-05-31 15743429 bus:RegisteredOffice 2025-06-01 2026-05-31 15743429 core:WithinOneYear 2026-05-31 15743429 core:AfterOneYear 2026-05-31 15743429 1 2025-06-01 2026-05-31 15743429 bus:Director1 2025-06-01 2026-05-31 15743429 bus:Director1 2026-05-31 15743429 bus:Director1 2024-05-26 2025-05-31 15743429 bus:Director2 2025-06-01 2026-05-31 15743429 bus:Director2 2026-05-31 15743429 bus:Director2 2024-05-26 2025-05-31 15743429 2024-05-26 15743429 bus:LeadAgentIfApplicable 2025-06-01 2026-05-31 15743429 2024-05-26 2025-05-31 15743429 2025-05-31 15743429 core:WithinOneYear 2025-05-31 15743429 core:AfterOneYear 2025-05-31 15743429 bus:EntityAccountantsOrAuditors 2024-05-26 2025-05-31 15743429 core:CostValuation core:Non-currentFinancialInstruments 2026-05-31 15743429 core:CostValuation core:Non-currentFinancialInstruments 2025-05-31 15743429 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-05-31 15743429 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 15743429 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-05-31 15743429 core:Non-currentFinancialInstruments 2026-05-31 15743429 core:Non-currentFinancialInstruments 2025-05-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 15743429
England and Wales
DERMA ZONE BY RAYCHEVA LTD
Abridged Accounts
Period of accounts Start date: 01 June 2025 End date: 31 May 2026

Derma zone by Raycheva Ltd Contents Page For the year ended 31 May 2026
Statement of Financial Position | 1

Derma zone by Raycheva Ltd Statement of Financial Position As at 31 May 2026
|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | 7,090 |  |  | 3,741 |
Creditors: amount falling due within one year |  | (1,347) |  |  | (711) |
Net current assets |  |  | 5,743 |  |  | 3,030
Total assets less current liabilities |  |  | 5,743 |  |  | 3,030
Net assets |  |  | 5,743 |  |  | 3,030
Capital and reserves |  |  | 5,743 |  |  | 3,030
NOTES TO THE ACCOUNTS General Information Derma zone by Raycheva Ltd is a private company, limited by shares, registered in England and Wales, registration number 15743429, registration address 2a Wilmer way, London, N14 7JB. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 5 (2025 : 5).
For the year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts. The financial statements were approved by the board of directors on 18 August 2026 and were signed on its behalf by:
-------------------------------- Ventsislav Raychev Director
1